Clarke W L, Santiago J V, Kipnis D M
Diabetes. 1978 Jun;27(6):649-52. doi: 10.2337/diab.27.6.649.
The effect of elevated glucagon concentrations on insulin requirements and on blood glucose concentrations was studied in five insulin-requiring diabetic subjects during feedback control of hyperglycemia with an automated glucose-controlled insulin infusion system (artificial endocrine pancreas) for six to eight hours. Two levels of hyperglucagonemia were induced by means of constant intravenous infusion. Raising plasma glucagon concentrations to levels reported in poorly controlled diabetics (450 to 665 pg. per milliliter) did not alter total insulin requirements or blood glucose concentrations. Higher glucagon concentrations (850 to 1,050 pg. per milliliter) caused a modest (26 per cent) increase in insulin requirements and only a slight increase in mean blood glucose concentrations. These studies demonstrate that the degree of hyperglucagonemia found most frequently in insulin-requiring diabetics does not increase insulin requirements or decrease insulin effectiveness in patients given insulin in amounts appropriate to maintain euglycemia.
在五名需要胰岛素治疗的糖尿病患者中,使用自动血糖控制胰岛素输注系统(人工内分泌胰腺)对高血糖进行六至八小时的反馈控制,研究了胰高血糖素浓度升高对胰岛素需求和血糖浓度的影响。通过持续静脉输注诱导出两种高胰高血糖素血症水平。将血浆胰高血糖素浓度提高到控制不佳的糖尿病患者中所报告的水平(每毫升450至665皮克),并未改变总胰岛素需求量或血糖浓度。更高的胰高血糖素浓度(每毫升850至1050皮克)使胰岛素需求量适度增加(26%),且平均血糖浓度仅略有升高。这些研究表明,在需要胰岛素治疗的糖尿病患者中最常发现的高胰高血糖素血症程度,并不会增加给予适量胰岛素以维持血糖正常的患者的胰岛素需求量,也不会降低胰岛素的有效性。